title: Reply: GnRHa trigger and modified luteal support with one bolus of hCG should be used with caution in extreme responder patients.
authors.forename: Baris
authors.initials: B
authors.lastname: Ata
authors.forename: Ayse
authors.initials: A
authors.lastname: Seyhan
authors.forename: Mehtap
authors.initials: M
authors.lastname: Polat
authors.forename: Weon Young
authors.initials: WY
authors.lastname: Son
authors.forename: Hakan
authors.initials: H
authors.lastname: Yarali
authors.forename: Michael
authors.initials: M
authors.lastname: Dahan
mesh_terms: D006063:Chorionic Gonadotropin / Q000009:adverse effects*; D003338:Corpus Luteum / Q000187:drug effects*; D005260:Female; D005300:Fertility Agents, Female / Q000009:adverse effects*; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006801:Humans; D016471:Ovarian Hyperstimulation Syndrome / Q000453:epidemiology*; D010053:Ovary / Q000187:drug effects*; D010062:Ovulation Induction / Q000009:adverse effects*
chemical_list: D006063:Chorionic Gonadotropin; D005300:Fertility Agents, Female; D007987:Gonadotropin-Releasing Hormone